RxDoctor Payments Data

Tareq Kass-Hout, MD

Vascular Neurology · Chicago, ILNPI 1144513359

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (51.3%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. 18 manufacturers reported payments, led by Microvention, Inc. at 54.0% of the total. 2025 is the largest year on record at $129,807, more than ten times the $323 reported in 2019. Among vascular neurology clinicians in IL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$336,283in general payments, 2019–2025

Across 390 payments — averaging $862.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Microvention, Inc.$182K
  • Imperative Care, Inc$35K
  • Medical Device Business Services, Inc.$33K
  • Philips North America LLC$19K
  • Medtronic$17K
  • Stryker$16K
  • plus $35K from 12 others
$78,041in research payments, 2019–2025

Across 4 payments — averaging $19,510 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Microvention, Inc.$66K
  • Medical Device Business Services, Inc.$11K
  • Amgen$1K
  • Sim&cure Inc$150

What the payments were for

  • Consulting fees$106,02632%
  • Speaking & faculty fees$172,34751%
  • Travel & lodging$45,57414%
  • Food & beverage$11,6083%
  • Education$4500%
  • Gifts$40%
  • Entertainment$2740%

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$336,283 in reported general payments places this provider in the 95th percentile of 32 vascular neurology providers in Illinois.

See all vascular neurology providers in Illinois

Medicare billing

Part B allowed, 2024
$139,604
Medicare patients
169
Services billed
440

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban18$13,835
BrilintaTicagrelor12$5,030
Ezetimibe12$438
Rosuvastatin Calcium25$434
Atorvastatin Calcium11$174
Losartan Potassium11$152

Paid to pharmacies, not to this prescriber.

Other vascular neurology in Chicago

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →